| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.125 | 223 | 0 | 7.903 | 35.278 | 85.618 | 261.736 | 403.349 | 499.819 | 802.122 |
| Total Income - EUR | 1.125 | 223 | 548 | 23.920 | 50.985 | 102.464 | 290.971 | 421.121 | 515.143 | 817.464 |
| Total Expenses - EUR | 200 | 43 | 428 | 23.378 | 48.730 | 72.384 | 177.208 | 212.811 | 326.285 | 550.998 |
| Gross Profit/Loss - EUR | 925 | 179 | 120 | 542 | 2.255 | 30.080 | 113.762 | 208.310 | 188.858 | 266.466 |
| Net Profit/Loss - EUR | 891 | 173 | 114 | 463 | 1.902 | 29.515 | 111.599 | 204.988 | 184.937 | 232.000 |
| Employees | 0 | 0 | 1 | 1 | 1 | 2 | 4 | 5 | 4 | 4 |
Check the financial reports for the company - Qestetic Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 217.565 | 195.775 | 175.115 | 154.623 | 186.175 | 166.061 | 117.795 | 113.962 |
| Current Assets | 8.787 | 8.884 | 204.534 | 12.929 | 2.452 | 23.154 | 91.226 | 201.842 | 164.111 | 199.984 |
| Inventories | 0 | 0 | 0 | 0 | 240 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 195.809 | 0 | 0 | 481 | 0 | 179.421 | 87.941 | 75.342 |
| Cash | 8.787 | 8.884 | 8.724 | 12.929 | 2.212 | 22.672 | 91.226 | 22.422 | 76.170 | 124.641 |
| Shareholders Funds | 8.116 | 8.206 | 8.181 | 8.493 | 10.231 | 34.797 | 111.663 | 205.041 | 184.990 | 234.021 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 672 | 678 | 218.109 | 24.013 | 10.258 | 4.289 | 46.203 | 58.072 | 74.123 | 68.360 |
| Income in Advance | 0 | 0 | 195.809 | 176.197 | 157.077 | 138.690 | 120.546 | 105.805 | 96.989 | 74.924 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Qestetic Med S.r.l.